Yuan Zhang
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway
Zhang, Yuan; Li, Xing; Ciric, Bogoljub; Ma, Cun Gen; Gran, Bruno; Rostami, Abdolmohamad; Zhang, Guang Xian
Authors
Xing Li
Bogoljub Ciric
Cun Gen Ma
Bruno Gran
Abdolmohamad Rostami
Guang Xian Zhang
Abstract
Natural compounds derived from medicinal plants have long been considered a rich source of novel therapeutic agents. Baicalin (Ba) is a bioactive flavonoid compound derived from the root of Scutellaria baicalensis, an herb widely used in traditional medicine for the treatment of various inflammatory diseases. In this study, we investigate the effects and mechanism of action of Ba in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Ba treatment effectively ameliorated clinical disease severity in myelin oligodendrocyte glycoprotein (MOG)35-55 peptide-induced EAE, and reduced inflammation and demyelination of the central nervous system (CNS). Ba reduced infiltration of immune cells into the CNS, inhibited expression of proinflammatory molecules and chemokines, and prevented Th1 and Th17 cell differentiation via STAT/NF B signaling pathways. Further, we showed that SOCS3 induction is essential to the effects of Ba, given that the inhibitory effect of Ba on pathogenic Th17 responses was largely abolished when SOCS3 signaling was knocked down. Taken together, our findings demonstrate that Ba has significant potential as a novel anti-inflammatory agent for therapy of autoimmune diseases such as MS.
Citation
Zhang, Y., Li, X., Ciric, B., Ma, C. G., Gran, B., Rostami, A., & Zhang, G. X. (2015). Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway. Scientific Reports, 5, Article 17407. https://doi.org/10.1038/srep17407
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 29, 2015 |
Online Publication Date | Nov 30, 2015 |
Publication Date | Nov 30, 2015 |
Deposit Date | Sep 29, 2020 |
Publicly Available Date | Oct 8, 2020 |
Journal | Scientific Reports |
Electronic ISSN | 2045-2322 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 5 |
Article Number | 17407 |
DOI | https://doi.org/10.1038/srep17407 |
Public URL | https://nottingham-repository.worktribe.com/output/3227401 |
Publisher URL | https://www.nature.com/articles/srep17407 |
Files
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway
(6.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search